Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | CCR2 | P41597 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15858412 | 0.90 | CHRM2 (0.35) | CHRM2CHRM4CHRM1CHRM3SSTR4 | |
| SCHEMBL18937957 | 0.82 | MMP8 (0.32) | CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL16200766 | 0.81 | CHRM2 (0.30) | CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL106966 | 0.80 | FKBP1A (0.36) | CHRM2CHRM4CHRM1CHRM3CCR2 | |
| SCHEMBL18802879 | 0.80 | FKBP1A (0.36) | CHRM2CHRM4CHRM1CHRM3CCR2 | |
| SCHEMBL18802861 | 0.80 | FKBP1A (0.36) | CHRM2CHRM4CHRM1CHRM3CCR2 | |
| SCHEMBL107891 | 0.78 | FKBP1A (0.37) | CHRM2CHRM4CHRM1CHRM3CCR2 | |
| SCHEMBL10243718 | 0.78 | PDK1 (0.34) | CHRM2CHRM4CHRM1CHRM3EPHX1 | |
| SCHEMBL21677330 | 0.78 | NAAA (0.45) | CHRM2CHRM1CHRM3NAAAEPHX1 | |
| SCHEMBL22373391 | 0.78 | ARG1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120003437-A1 | PHOTOSENSITIVE COMPOSITION, PATTERN FORMING MATERIAL AND PHOTOSENSITIVE FILM USING THE SAME, PATTERN FORMING METHOD, PATTERN FILM, ANTIREFLECTION FILM, INSULATING FILM, OPTICAL DEVICE, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2012-01-05 | — | — | US | disclosed |
| US-20110089385-A1 | COMPOSITION FOR OPTICAL MATERIALS | FUJIFILM CORPORATION (JP) | 2011-04-21 | — | — | US | disclosed |
| EP-1829850-A2 | Fluoroalcohol preparation method, fluorinated monomer, polymer, resist composition and patterning process | Shin-Etsu Chemical Co., Ltd. (JP) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110089385-A1 | COMPOSITION FOR OPTICAL MATERIALS | ITGA1, PIEZO1, RPS4X | CHRM2 271/4885CHRM4 704/4885CHRM1 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.